|
gptkbp:instanceOf
|
gptkb:Company
|
|
gptkbp:activeDuring
|
gptkb:afoxolaner
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availableIn
|
various flavors
|
|
gptkbp:availableSizes
|
15 mg
3 mg
30 mg
120 mg
60 mg
7.5 mg
|
|
gptkbp:brand
|
gptkb:NexGard
|
|
gptkbp:clinicalTrials
|
demonstrated efficacy against fleas
demonstrated efficacy against ticks
|
|
gptkbp:colors
|
brown
|
|
gptkbp:contraindication
|
hypersensitivity_to_afoxolaner
|
|
gptkbp:dosageForm
|
oral
|
|
gptkbp:drugInterdiction
|
true
|
|
gptkbp:flavorProfile
|
beef
|
|
gptkbp:fledgingPeriod
|
none required
|
|
gptkbp:formFactor
|
chewable tablet
|
|
gptkbp:frequency
|
monthly
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NexGard Chewables
|
|
gptkbp:interactsWith
|
none reported
|
|
gptkbp:isRecognizedFor
|
dogs weighing less than 2 pounds
puppies under 8 weeks
|
|
gptkbp:lastProduced
|
2013
|
|
gptkbp:manufacturer
|
Merial
|
|
gptkbp:marketedAs
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:priceRange
|
$20 to $60
|
|
gptkbp:safetyFeatures
|
generally safe
|
|
gptkbp:shape
|
round
|
|
gptkbp:shelfLife
|
24 months
|
|
gptkbp:sideEffect
|
vomiting
diarrhea
lethargy
loss of appetite
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:suitableFor
|
veterinarians
|
|
gptkbp:targets
|
dogs
|
|
gptkbp:triggerType
|
disrupts nervous system of parasites
inhibits_GABA_receptor
|
|
gptkbp:usedFor
|
treating fleas
treating ticks
|
|
gptkbp:userReviews
|
generally positive
|
|
gptkbp:weight
|
2 to 120 pounds
|